[Changes in the indices of lipid metabolism in patients with ischemic heart disease occupied in natural gas fields]. 2003

A N Tin'kov, and S S Makshantsev, and A B Prokof'ev, and S V Perepelkin

The influence of adaptation to periodic pressure-chamber hypoxia produced on the condition of the lipid spectrum of blood serum before and after adaptation as well as in 3, 6 and 10 months after hypoxic training was studied in 46 patients with ischemic heart disease working at a enterprise specializing in winning and processing the hydrogen-sulfide-containing gas-condensate. The adaptation therapy was found to result in a reliable reduction of the total cholesterol level, of the level of cholesterol of lipoproteins of the low and extra low densities and of triglycerides; it also contributed to the increase of cholesterol of lipoproteins of the high density in blood serum, which, in the end, ensures a reduced atherogenic coefficient. The positive-for-organism changes in the lipid spectrum of blood serum hold on in patients with coronary heart disease for as long as 6 months after the adaptation therapy. The nature and degree of blood lipids' changes depend on an initial level of the atherogenic index; they were maximally pronounced in persons with the index exceeding 3, and virtually absent in IHD patients with the atherogenicity coefficient being below the mentioned figure.

UI MeSH Term Description Entries
D007221 Industry Any enterprise centered on the processing, assembly, production, or marketing of a line of products, services, commodities, or merchandise, in a particular field often named after its principal product. Examples include the automobile, fishing, music, publishing, insurance, and textile industries. Tertiary Sector,Industries,Sector, Tertiary,Sectors, Tertiary,Tertiary Sectors
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009784 Occupational Diseases Diseases caused by factors involved in one's employment. Diseases, Occupational,Occupational Illnesses,Disease, Occupational,Illnesse, Occupational,Illnesses, Occupational,Occupational Disease,Occupational Illnesse
D005579 Fossil Fuels Any combustible hydrocarbon deposit formed from the remains of prehistoric organisms. Examples are petroleum, coal, and natural gas. Fossil Fuel,Fuel, Fossil,Fuels, Fossil
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014280 Triglycerides An ester formed from GLYCEROL and three fatty acid groups. Triacylglycerol,Triacylglycerols,Triglyceride
D015243 Cholesterol, VLDL Cholesterol which is contained in or bound to very low density lipoproteins (VLDL). High circulating levels of VLDL cholesterol are found in HYPERLIPOPROTEINEMIA TYPE IIB. The cholesterol on the VLDL is eventually delivered by LOW-DENSITY LIPOPROTEINS to the tissues after the catabolism of VLDL to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LDL. VLDL Cholesterol,Pre-beta-Lipoprotein Cholesterol,Prebetalipoprotein Cholesterol,Very Low Density Lipoprotein Cholesterol,Cholesterol, Pre-beta-Lipoprotein,Cholesterol, Prebetalipoprotein,Pre beta Lipoprotein Cholesterol
D017202 Myocardial Ischemia A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION). Heart Disease, Ischemic,Ischemia, Myocardial,Ischemic Heart Disease,Disease, Ischemic Heart,Diseases, Ischemic Heart,Heart Diseases, Ischemic,Ischemias, Myocardial,Ischemic Heart Diseases,Myocardial Ischemias

Related Publications

A N Tin'kov, and S S Makshantsev, and A B Prokof'ev, and S V Perepelkin
October 1983, Vrachebnoe delo,
A N Tin'kov, and S S Makshantsev, and A B Prokof'ev, and S V Perepelkin
April 1988, Klinicheskaia meditsina,
A N Tin'kov, and S S Makshantsev, and A B Prokof'ev, and S V Perepelkin
January 1988, Voprosy pitaniia,
A N Tin'kov, and S S Makshantsev, and A B Prokof'ev, and S V Perepelkin
September 1990, Kardiologiia,
A N Tin'kov, and S S Makshantsev, and A B Prokof'ev, and S V Perepelkin
January 1988, Voprosy meditsinskoi khimii,
A N Tin'kov, and S S Makshantsev, and A B Prokof'ev, and S V Perepelkin
August 1983, Vrachebnoe delo,
A N Tin'kov, and S S Makshantsev, and A B Prokof'ev, and S V Perepelkin
January 1989, Vrachebnoe delo,
A N Tin'kov, and S S Makshantsev, and A B Prokof'ev, and S V Perepelkin
June 1972, Kardiologiia,
A N Tin'kov, and S S Makshantsev, and A B Prokof'ev, and S V Perepelkin
October 1990, Molekuliarnaia genetika, mikrobiologiia i virusologiia,
A N Tin'kov, and S S Makshantsev, and A B Prokof'ev, and S V Perepelkin
January 1996, Likars'ka sprava,
Copied contents to your clipboard!